In the US, Toxoplasma gondii is the second leading cause of food borne mortality and more than 60 million people are persistently infected with this organism and this infection is a concern in many patients with primary or acquired defects in T cell mediated immunity. Due to the ease of transmission and its ability to cause severe disease, T. gondii is classified as a Class B Biodefense pathogen. The ability to balance the development of protective and pathological immunity is key in determining the outcome of this infection. This proposal studies the role of the cytokine IL-27 in controllinga unique population of regulatory T cells to limit inflammation and is broadly applicable to understanding how this cytokine may be useful as a therapy.
Toxoplasma is a common opportunistic infection in patients with defects in T cell function and can cause significant disease in immune competent individuals. The ability to control the inflammatory response to this infection is essential to limt collateral damage and key to host cell survival. The overall goal of this proposal is to understand how the cytokine IL-27 controls the inflammatory response with the overarching goal of developing therapies that are useful to modulate the immune system.
|Pritchard, Gretchen Harms; Cross, Eric W; Strobel, Marjorie et al. (2016) Spontaneous partial loss of the OT-I transgene. Nat Immunol 17:471|
|Silver, Jonathan S; Kearley, Jennifer; Copenhaver, Alan M et al. (2016) Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs. Nat Immunol 17:626-35|
|Yoshida, Hiroki; Hunter, Christopher A (2015) The immunobiology of interleukin-27. Annu Rev Immunol 33:417-43|
|Harms Pritchard, Gretchen; Hall, Aisling O'Hara; Christian, David A et al. (2015) Diverse roles for T-bet in the effector responses required for resistance to infection. J Immunol 194:1131-40|
|Hirahara, Kiyoshi; Onodera, Atsushi; Villarino, Alejandro V et al. (2015) Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine Specificity. Immunity 42:877-89|
|Lee, Hyang-Mi; Fleige, Anne; Forman, Ruth et al. (2015) IFNÎ³ signaling endows DCs with the capacity to control type I inflammation during parasitic infection through promoting T-bet+ regulatory T cells. PLoS Pathog 11:e1004635|
|Wagage, Sagie; Harms Pritchard, Gretchen; Dawson, Lucas et al. (2015) The Group 3 Innate Lymphoid Cell Defect in Aryl Hydrocarbon Receptor Deficient Mice Is Associated with T Cell Hyperactivation during Intestinal Infection. PLoS One 10:e0128335|
|Wagage, Sagie; John, Beena; Krock, Bryan L et al. (2014) The aryl hydrocarbon receptor promotes IL-10 production by NK cells. J Immunol 192:1661-70|
|Glatman Zaretsky, Arielle; Engiles, Julie B; Hunter, Christopher A (2014) Infection-induced changes in hematopoiesis. J Immunol 192:27-33|